Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice
Open Access
- 19 April 2018
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (8)
Abstract
Preeclampsia (PE), associates with long-term increased risk for cardiovascular disease in women, suggesting that PE is not an isolated disease of pregnancy. It is not known if increased risk for long-term diseases is due to PE-specific factors or to prepregnancy renal and cardiovascular risk factors. We used a mouse model in which a WT female with normal prepregnancy health develops PE to investigate if preeclampsia causes long-term cardiovascular consequences after pregnancy for mothers and offspring. Mothers exhibited endothelial dysfunction and hypertension after PE and had glomerular injury that not only persisted but deteriorated, leading to fibrosis. Left ventricular (LV) remodeling characterized by increased collagen deposition and MMP-9 expression and enlarged cardiomyocytes were also detected after PE. Increased LV internal wall thickness and mass, increased end diastolic and end systolic volumes, and increased stroke volume were observed after PE in the mothers. Placenta-derived bioactive factors that modulate vascular function, markers of metabolic disease, vasoconstrictor isoprostane-8, and proinflammatory mediators were increased in sera during and after a preeclamptic pregnancy in the mother. Offspring of PE mice developed endothelial dysfunction, hypertension, and signs of metabolic disease. Microglia activation was increased in the neonatal brains after PE, suggesting neurogenic hypertension in offspring. Prevention of placental insufficiency with pravastatin prevented PE-associated cardiovascular complications in both mothers and offspring. In conclusion, factors that develop during PE have long-term, cardiovascular effects in the mother and offspring independent of prepregnancy risk factors.Keywords
Funding Information
- Tommy’s Charity (2016X32)
- Theirworld (20765AS2)
This publication has 64 references indexed in Scilit:
- Role of Exosomes in Placental Homeostasis and Pregnancy Disorders2017
- Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2016
- Maternal cardiac remodeling and dysfunction in preeclampsia: a three-dimensional speckle-tracking echocardiography studyThe International Journal of Cardiovascular Imaging, 2015
- The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine modelAmerican Journal of Obstetrics and Gynecology, 2014
- Transplacental transfer and distribution of pravastatinAmerican Journal of Obstetrics and Gynecology, 2013
- Relation of Leptin to Left Ventricular Hypertrophy (from the Multi-Ethnic Study of Atherosclerosis)The American Journal of Cardiology, 2013
- Prepregnancy obesity and sFlt1-induced preeclampsia in mice: developmental programming model of metabolic syndromeAmerican Journal of Obstetrics and Gynecology, 2011
- Non-invasive Blood Pressure Measurement in Mice2009
- Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analysesAmerican Heart Journal, 2008
- Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slicesGlia, 2001